Prevalence of comorbid asthma in Tunisian patients with COVID-19: clinical features and outcomes

Authors

  • Imen Ben Rebeh Laboratory of Molecular and Cellular Screening Processes, Center of Biotechnology of Sfax, University of Sfax, Sfax, Tunisia
  • Marwa Gargouri Department of Infectious Diseases, University Hospital Mohamed Sassi, Gabes, Tunisia
  • Marwa Ghariani Laboratory of Molecular and Cellular Screening Processes, Center of Biotechnology of Sfax, University of Sfax, Sfax, Tunisia https://orcid.org/0000-0003-1347-3547
  • Nesrine Kallel Department of Pneumology, CHU Hedi Chaker, Sfax, Tunisia
  • Sana Rouis COVID Unit, Ibn Jazzar Kairouan Hospital, Kairouan, Tunisia https://orcid.org/0000-0003-2858-5314
  • Wafa Marrakchi Department of Infectious Diseases, CHU Fattouma Bourguiba, Monastir, Tunisia https://orcid.org/0000-0002-0634-9188
  • Dhekra Chebil Department of Preventive Medicine, Hospital Ibn Jazzar, Kairouan, Tunisia https://orcid.org/0000-0001-7918-8568
  • Riadh Ben Marzoug Laboratory of Molecular and Cellular Screening Processes, Center of Biotechnology of Sfax, University of Sfax, Sfax, Tunisia https://orcid.org/0000-0003-2184-6323
  • Hela Gargouri Laboratory of Molecular and Cellular Screening Processes, Center of Biotechnology of Sfax, University of Sfax, Sfax, Tunisia https://orcid.org/0000-0002-3275-1816
  • Latifa Merzougui Department of Preventive Medicine, Hospital Ibn Jazzar, Kairouan, Tunisia
  • Houda Ghorbel Department of Infectious Diseases, University Hospital Mohamed Sassi, Gabes, Tunisia
  • Mohamed Chakroun Department of Infectious Diseases, CHU Fattouma Bourguiba, Monastir, Tunisia
  • Hassen Hadj Kacem Department of Applied Biology, College of Sciences, University of Sharjah, Sharjah, United Arab Emirates https://orcid.org/0000-0002-1884-2973
  • Ahmed Rebai Laboratory of Molecular and Cellular Screening Processes, Center of Biotechnology of Sfax, University of Sfax, Sfax, Tunisia

DOI:

https://doi.org/10.3855/jidc.17485

Keywords:

COVID-19, asthma, severity, comorbidity

Abstract

Introduction: The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has resulted in around 1 million COVID-19 infection cases and over 29,000 deaths in Tunisia thus far. There is great variability in the prevalence of asthma among patients with COVID-19, but the impact of asthma on patients with COVID-19 is not clear. We sought to describe the clinical features of Tunisian patients with COVID-19 and to compare asthmatic and non-asthmatic patients.

Methodology: This retrospective study included 675 Tunisian patients who were hospitalized with COVID-19. Clinical characteristics were collected from medical records. Bivariate analyses and multivariate regression models were used to assess the associations between asthma and the risk of severe symptoms, including death/recovery.

Results: The prevalence of asthma in the sample was 14.5%. The results show that asthmatic patients with COVID-19 have significantly less severe symptoms and better outcomes than non-asthmatic patients.

Conclusions: Asthma was not found to be associated with higher severity or worse prognosis among patients with COVID-19 in Tunisia.

Downloads

Published

2023-12-31

How to Cite

1.
Ben Rebeh I, Gargouri M, Ghariani M, Kallel N, Rouis S, Marrakchi W, Chebil D, Ben Marzoug R, Gargouri H, Merzougui L, Ghorbel H, Chakroun M, Hadj Kacem H, Rebai A (2023) Prevalence of comorbid asthma in Tunisian patients with COVID-19: clinical features and outcomes. J Infect Dev Ctries 17:1706–1713. doi: 10.3855/jidc.17485

Issue

Section

Coronavirus Pandemic